DavidA HWhitemanMDFAAP FACMG

Clinical Biochemical Genetics, Clinical Biochemical/Molecular Genetics, Clinical Cytogenetics, Clinical Genetics

VP, Research & Development, Global Program Leader, Rare Metabolic Diseases, Takeda Pharmaceuticals

Dr. Whiteman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Children's Hospital of PhiladelphiaFellowship, Medical Genetics and Genomics, 1982 - 1985
Oxford University Medical SchoolClass of 1978

PubMed

77 citations
Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Susan J. Jordan, Adèle C. Green, David C. Whiteman, Suzanne P. Moore, Chris Bain
International Journal of Cancer. 2007-11-30
54 citations
The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's ...
Jay H. Lubin, Michael B. Cook, Nirmala Pandeya, Thomas L. Vaughan, Christian C. Abnet
Cancer Epidemiology. 2012-06-01
35 citations
Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population.
Torukiri I. Ibiebele, Maria Celia B. Hughes, Christina M. Nagle, Chris Bain, David C. Whiteman
International Journal of Cancer. 2013-07-01